TMO Thermo Fisher Scientific Inc Common Stock
$615,25
Kurs · Aug 19, 2026
Fundamentaldaten per Jul 31, 2026
52W-Spanne
$435–$644
86% of range
Analystenbewertung
BUY
36 analysts
Kursziel
$631
+3% upside
P/E (TTM)
34.7
ROE
13.0%
Nettogewinnmarge
15.0%
Über Thermo Fisher Scientific Inc Common Stock Unternehmensübersicht von Wikipedia
Thermo Fisher Scientific Inc., kurz auch Thermo Fisher, ist ein US-amerikanisches Technologieunternehmen mit Sitz in Waltham, Massachusetts. Es beschreibt sich selbst als „der weltweit größte Lieferant für wissenschaftliche Anwendungen.“
Mehr lesen
Thermo Fisher Scientific Inc. (NYSE: TMO), kurz auch Thermo Fisher, ist ein US-amerikanisches Technologieunternehmen mit Sitz in Waltham, Massachusetts. Es beschreibt sich selbst als „der weltweit größte Lieferant für wissenschaftliche Anwendungen.“
Firmengeschichte
Thermo Fisher Scientific entstand im November 2006 mit der Übernahme der Fisher Scientific International Inc. durch die Thermo Electron Corp. und dessen Subunternehmen ThermoQuest.
Die Thermo Electron Corp., die 1956 gegründet worden war, hatte allerdings bereits zuvor zahlreiche Analytikfirmen (wie z. B. Finnigan MAT, Fisons instruments (teilweise), Carlo Erba strumentazione, Nicolet Instrument Corporation) erworben, deren Aktivitäten nun unter dem Dach von Thermo Fisher Scientific zusammengefasst wurden. Seit dem 17. Mai 2011 ist auch die Dionex Corporation offiziell ein Teil der Thermo Fisher Scientific Unternehmensgruppe.
Ende 2009 wurde das Biotech-Unternehmen Brahms übernommen. Im Mai 2011 kaufte Thermo Fisher für 2,47 Milliarden € die Firma Phadia, die Tests für Allergien und Autoimmunerkrankungen herstellt.
Im April 2013 kündigte Thermo Fisher nach einem Bieterwettstreit mit Hoffmann-La Roche an, dass es Life Technologies für 13,6 Milliarden US-Dollar übernehmen werde. Diese Übernahme wurde im Februar 2014 vollzogen. 2015 erwarb Thermo-Fisher Alfa Aesar und baute so das Portfolio im Bereich der Laborchemikalien aus. 2016 erwarb Thermo Fisher das Unternehmen FEI für 4,2 Mrd. USD und 2017 das Unternehmen Patheon für 7,2 Mrd. USD.
Im März 2020 gab das Unternehmen ein öffentliches Übernahmeangebot für den deutschen Hersteller von Testtechnologien Qiagen bekannt; dabei sollten mindestens 75 Prozent der Aktien zu 39 Euro pro Aktie, ca. 23 Prozent über dem damaligen Qiagen Börsenkurs, aufgekauft werden. Die Offerte wurde durch Vorstand und Aufsichtsrat von Qiagen unterstützt.
Später wurde das Angebot auf 43 Euro erhöht und die Annahmeschwelle auf 66,66 Prozent gesenkt. Das Übernahmeangebot lief im August 2020 aus, bis zu diesem Zeitpunkt waren jedoch lediglich 47 Prozent der Aktien angedient worden, so dass die geplante Übernahme scheiterte. Qiagen musste daraufhin eine vertraglich vereinbarte Kostenerstattung in Höhe von 95 Millionen US-Dollar an Thermo Fisher zahlen.
Produkte
Ein Hauptprodukt von Thermo Fisher sind Kopplungstechniken von Massenspektrometern mit Chromatographiegeräten. Unter anderem werden Massenspektrometer mit der Quadrupol- (ISQ, TSQ), der Ionenfallentechnik (ion trap) und Orbitrap-Massenspektrometer sowohl in Form einfacher als auch mehrfacher Massenspektrometer angeboten.
Analysengeräte können in Form von Gaschromatographen (GC), Flüssigkeitschromatographen (HPLC), Kapillarelektrophorese (CE) und Massenspektrometrie mit induktiv gekoppeltem Plasma (ICP–MS) gekoppelt werden. Für die Chromatographiegeräte werden auch weitere Detektoren angeboten.
Weitere Produkte umfassen folgende Analysentechniken:
AAS (Atomabsorptionspektrometrie)
FT-IR-Spektroskopie
Elektronenmikroskopie
Infrarotmikroskopie
Ionenchromatographie
Laborextruder, Labormixer
Neutronengeneratoren
Nah-Infrarot-Analysegeräte
OES (Atomemissionsspektrometrie)
Raman-Spektroskopie
Rheometer, Viskosimeter
Röntgen-Photoelektronenspektroskopie
UV-Vis-Spektrophotometer
XRF/XRD (energie- und wellenlängendispersive Röntgenfluoreszenzanalyse)
Thermo Fisher Scientific entwickelt auch entsprechende Chromatographie-Auswertesoftware (z. B. Xcalibur und Dionex Chromeleon) und Labor-Informations- und Management-Systeme (LIMS).
Die Firma ist darüber hinaus ein weltweit führender Anbieter von Laborverbrauchsmaterialien und -chemikalien.
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
TMO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$615.25
Marktkapitalisierung
$273.79B
P/E (TTM)
34.7
EPS (TTM)
$17.74
Umsatz (TTM)
$44.56B
Dividendenrendite
0.24%
ROE
13.0%
Verschuldungsgrad
—
52W-Spanne
$435 – $644
TMO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$44.56B
2021-12-31
→
2025-12-31
EPS
$17.74
2021-12-31
→
2025-12-31
Freier Cashflow
$6.29B
2021-12-31
→
2025-12-31
Margen
15.0%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
TMO
Peer-Median
P/E (TTM)
34.7
17.5
P/S (TTM) (K/V (TTM))
6.1
3.3
P/B (K/B)
5.1
2.1
Price / FCF (Kurs / FCF)
43.5
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
TMO
Peer-Median
Operating Margin (Betriebsgewinnmarge)
17.4%
—
Net Profit Margin (Nettogewinnmarge)
15.0%
-56.5%
ROA
6.5%
-17.2%
ROE
13.0%
-41.3%
ROIC
13.4%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
TMO
Peer-Median
Current Ratio (Liquiditätsgrad)
1.9
4.9
Quick Ratio
1.3
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
TMO
Peer-Median
Revenue YoY (Umsatz YoY)
3.9%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
-0.27%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
6.7%
—
EPS YoY (EPS VjV)
7.3%
—
Net Income YoY (Nettogewinn YoY)
5.8%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
TMO
Peer-Median
Payout Ratio (Ausschüttungsquote)
9.5%
—
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite
0.24%
Ausschüttungsquote
9.5%
5J Div CAGR
—
| Ex-Datum | Betrag |
|---|---|
| 15. Juni 2026 | $0,4700 |
| 13. März 2026 | $0,4700 |
| 15. Dezember 2025 | $0,4300 |
| 15. September 2025 | $0,4300 |
| 13. Juni 2025 | $0,4300 |
| 14. März 2025 | $0,4300 |
| 13. Dezember 2024 | $0,3900 |
| 13. September 2024 | $0,3900 |
| 14. Juni 2024 | $0,3900 |
| 14. März 2024 | $0,3900 |
| 14. Dezember 2023 | $0,3500 |
| 14. September 2023 | $0,3500 |
| 14. Juni 2023 | $0,3500 |
| 14. März 2023 | $0,3500 |
| 14. Dezember 2022 | $0,3000 |
| 14. September 2022 | $0,3000 |
| 14. Juni 2022 | $0,3000 |
| 15. März 2022 | $0,3000 |
| 14. Dezember 2021 | $0,2600 |
| 14. September 2021 | $0,2600 |
TMO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
36 Analysten
- Starker Kauf 11 30,6%
- Kauf 18 50,0%
- Halten 7 19,4%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
26 Analysten · 2026-08-14
Median
$642.50
Jetzt
$615.25
Tief
$520.00
Hoch
$750.00
Median-Ziel
$642.50
+4,4%
Mittelwert-Ziel
$631.42
+2,6%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.13%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $6.03 | $5.77 | 0.26% |
| 31. März 2026 | $5.44 | $5.29 | 0.15% |
| 31. Dezember 2025 | $6.57 | $6.51 | 0.06% |
| 30. September 2025 | $5.79 | $5.55 | 0.24% |
| 30. Juni 2025 | $5.36 | $5.28 | 0.08% |
| 31. März 2025 | $5.15 | $5.15 | -0.00% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | — |
| DHR | $161.82B | 45.3 | 2.9% | 14.7% | 7.1% | 59.1% |
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | — |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | — |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | — |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44.56B | $42.88B | $42.86B | $44.91B | $39.21B | $32.22B | $25.54B | $24.36B | · | $18.27B | $16.96B | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | $8.21B | $7.58B | |
| R&D Expense | $1.40B | $1.39B | $1.34B | $1.47B | $1.41B | $1.18B | $1.00B | $967M | · | $754M | $692M | |
| SG&A Expense | $8.73B | $8.60B | $8.45B | $8.99B | $8.01B | $6.93B | $6.14B | $6.06B | · | $4.97B | $4.61B | |
| Operating Expenses | $36.81B | $35.54B | $36.00B | $36.52B | $29.18B | $24.42B | $20.95B | $20.57B | · | $15.82B | $14.63B | |
| Operating Income | $7.75B | $7.34B | $6.86B | $8.39B | $10.03B | $7.79B | $4.59B | $3.78B | · | $2.46B | $2.34B | |
| Interest Expense | · | · | $1.38B | $726M | $536M | $553M | $676M | $667M | · | $469M | $415M | |
| Interest Income | $993M | $1.08B | $879M | $272M | $43M | $65M | $224M | $137M | · | $48M | $31M | |
| Other Non-op | $-12M | $12M | $-65M | $-104M | $-694M | $-76M | $-70M | $9M | · | $-13M | $-16M | |
| Pretax Income | $7.31B | $7.04B | $6.30B | $7.83B | $8.84B | $7.23B | $4.07B | $3.26B | · | $2.02B | $1.94B | |
| Income Tax | $547M | $657M | $284M | $703M | $1.11B | $850M | $374M | $324M | · | $-1M | $-44M | |
| Net Income | $6.70B | $6.33B | $6.00B | $6.96B | $7.73B | $6.38B | $3.70B | · | · | · | · | |
| EPS (Basic) | $17.77 | $16.58 | $15.52 | $17.75 | $19.62 | $16.09 | $9.24 | $7.31 | · | $5.12 | $4.96 | |
| EPS (Diluted) | $17.74 | $16.53 | $15.45 | $17.63 | $19.46 | $15.96 | $9.17 | $7.24 | · | $5.09 | $4.92 | |
| Shares (Basic) | 377,000,000 | 382,000,000 | 386,000,000 | 392,000,000 | 394,000,000 | 396,000,000 | 400,000,000 | 402,000,000 | · | 395,000,000 | 399,000,000 | |
| Shares (Diluted) | 378,000,000 | 383,000,000 | 388,000,000 | 394,000,000 | 397,000,000 | 399,000,000 | 403,000,000 | 406,000,000 | · | 397,000,000 | 402,000,000 | |
| EBITDA | $7.75B | $7.34B | $6.86B | $8.39B | $10.03B | $7.79B | $4.59B | $6.05B | · | $4.21B | $4.02B |
Bilanz 28
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9.85B | $4.01B | $8.08B | $8.52B | $4.48B | $10.32B | $2.40B | $2.10B | · | $786M | $452M | |
| Short-term Investments | $253M | $1.56B | $3M | · | · | · | · | · | · | · | · | |
| Receivables | $8.90B | $8.19B | $8.22B | $8.12B | $7.98B | $5.74B | $4.35B | $4.14B | $3.87B | $3.05B | $2.54B | |
| Inventory | $5.42B | $4.98B | $5.09B | $5.63B | $5.05B | $4.03B | $3.37B | $3.00B | $2.72B | $2.21B | $1.99B | |
| Other Current Assets | $2.61B | $1.96B | $1.76B | $1.64B | $1.64B | $1.13B | $1.17B | $922M | $1.47B | $595M | $534M | |
| Current Assets | $28.71B | $22.14B | $24.59B | $25.23B | $20.11B | $21.96B | $11.89B | $10.62B | · | $7.02B | $5.74B | |
| PP&E (Net) | $10.56B | $9.31B | $9.45B | $9.28B | $8.33B | $5.91B | $4.75B | $4.17B | · | $2.58B | $2.45B | |
| PP&E (Gross) | $18.38B | $16.06B | $15.52B | $14.27B | $12.59B | $9.58B | $7.76B | $6.82B | · | $4.42B | $4.11B | |
| Accum. Depreciation | $7.82B | $6.75B | $6.08B | $4.99B | $4.26B | $3.67B | $3.02B | $2.65B | · | $1.84B | $1.66B | |
| Goodwill | $49.36B | $45.85B | $44.02B | $41.20B | $41.92B | $26.04B | $25.71B | $25.35B | · | $21.33B | $18.83B | |
| Intangibles | $15.84B | $15.53B | $16.67B | $17.44B | $20.11B | $12.69B | $14.01B | $14.98B | · | $13.97B | $12.76B | |
| Other Non-current Assets | $5.87B | $4.49B | $4.00B | $4.01B | $4.64B | $2.46B | $2.01B | $1.12B | $1.17B | $1.01B | $1.06B | |
| Total Assets | $110.34B | $97.32B | $98.73B | $97.15B | $95.12B | $69.05B | $58.38B | $56.23B | · | $45.91B | $40.83B | |
| Accounts Payable | $3.62B | $3.08B | $2.87B | $3.38B | $2.87B | $2.17B | $1.92B | $1.61B | · | $926M | $822M | |
| Short-term Debt | · | · | · | · | · | · | · | $693M | · | $953M | $50M | |
| Current Liabilities | $15.19B | $13.33B | $14.01B | $17.01B | $13.44B | $10.30B | $6.20B | $6.15B | · | $4.87B | $4.15B | |
| Capital Leases | $1.20B | $1.24B | $1.24B | $1.31B | $1.20B | $626M | $571M | · | · | · | · | |
| Deferred Tax | $1.49B | $1.27B | $1.92B | $2.85B | $3.84B | $1.79B | $2.19B | $2.27B | $2.71B | $2.56B | $2.62B | |
| Other Non-current Liabilities | $4.27B | $3.99B | $4.64B | $4.24B | $4.54B | $3.33B | $3.24B | $2.52B | $2.64B | $1.57B | $1.29B | |
| Long-term Debt | $39.17B | $31.07B | $34.73B | $34.28B | $34.67B | $21.73B | $17.75B | $18.99B | · | · | · | |
| Total Debt | · | · | · | · | · | $19.11B | $17.08B | $693M | · | $953M | $50M | |
| Common Stock | $445M | $444M | $442M | $441M | $439M | $437M | $434M | $432M | · | $415M | $412M | |
| Retained Earnings | $59.16B | $53.10B | $47.36B | $41.91B | $35.43B | $28.12B | $22.09B | $18.70B | $16.03B | $13.93B | $12.14B | |
| Treasury Stock | $22.31B | $19.23B | $15.13B | $12.02B | $8.92B | $6.82B | $5.24B | $3.67B | · | $2.31B | $1.01B | |
| AOCI | $-2.45B | $-2.70B | $-3.22B | $-3.10B | $-2.33B | $-2.81B | $-2.68B | $-2.50B | $-2.09B | $-2.64B | $-2.00B | |
| Stockholders' Equity | $53.41B | $49.58B | $46.73B | $43.98B | $40.79B | $34.51B | $29.68B | $27.59B | · | $21.54B | $21.35B | |
| Liabilities + Equity | $110.34B | $97.32B | $98.73B | $97.15B | $95.12B | $69.05B | $58.38B | $56.23B | · | $45.91B | $40.83B | |
| Shares Outstanding | 445,000,000 | 444,000,000 | 442,000,000 | 441,000,000 | 439,000,000 | 437,000,000 | 434,000,000 | · | · | · | · |
Cashflow 19
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $2.27B | · | $1.76B | $1.69B | |
| Stock-based Comp | $310M | $301M | $278M | $307M | $230M | $196M | $181M | $181M | · | $133M | $125M | |
| Deferred Tax | $-639M | $-1.21B | $-1.30B | $-997M | $-645M | $-269M | $-499M | $-474M | · | $-639M | $-600M | |
| Amort. of Intangibles | $1.73B | $1.95B | $2.34B | $2.40B | $1.76B | $1.67B | $1.71B | $1.74B | · | $1.38B | $1.31B | |
| Restructuring | $197M | $97M | $194M | $68M | $37M | $51M | $52M | $88M | · | $167M | $90M | |
| Operating Cash Flow | $7.82B | $8.67B | $8.41B | $9.15B | $9.31B | $8.29B | $4.97B | $4.54B | · | $3.26B | $2.94B | |
| CapEx | $1.52B | $1.40B | $1.48B | $2.24B | $2.52B | $1.47B | $926M | $758M | · | $444M | $423M | |
| Investing Cash Flow | $-4.05B | $-5.84B | $-5.14B | $-2.16B | $-21.93B | $-1.51B | $-1.49B | $-1.25B | · | $-5.52B | $-1.09B | |
| Debt Issued | $7.76B | $1.20B | $5.94B | $3.19B | $18.14B | $3.46B | $5.64B | $690M | · | $7.60B | $1.80B | |
| Net Debt Issued | $5.35B | $-2.40B | $160M | $2.82B | $6.40B | $2.75B | $-722M | $-1.36B | · | $3.27B | $-1.98B | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | · | $0 | $0 | |
| Stock Repurchased | $3.00B | $4.00B | $3.00B | $3.00B | $2.00B | $1.50B | $1.50B | $500M | · | $1.25B | $500M | |
| Net Stock Activity | $-3.00B | $-4.00B | $-3.00B | $-3.00B | $-2.00B | $-1.50B | $-1.50B | $-500M | · | $-1.25B | $-500M | |
| Dividends Paid | $636M | $583M | $523M | $455M | $395M | $337M | $297M | $266M | · | $238M | $241M | |
| Financing Cash Flow | $1.80B | $-6.79B | $-3.62B | $-2.81B | $6.58B | $959M | $-3.12B | $-2.24B | · | $2.76B | $-2.62B | |
| Net Change in Cash | $5.84B | $-4.06B | $-440M | $4.05B | $-5.84B | $7.91B | $305M | $756M | · | $345M | $-898M | |
| Taxes Paid | $1.78B | $1.83B | $1.48B | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $6.29B | $7.27B | $6.93B | $6.91B | $6.79B | $6.82B | $4.05B | $3.79B | · | $2.71B | $2.39B | |
| Levered FCF | · | · | $5.61B | $6.25B | $6.32B | $6.33B | $3.43B | $3.18B | · | $2.24B | $1.97B |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 17.4% | 17.1% | 16.0% | 18.7% | 25.6% | 24.2% | 18.0% | 15.5% | · | 13.4% | 13.8% | |
| Net Margin | 15.0% | 14.8% | 13.9% | 15.5% | 19.7% | · | · | · | · | · | · | |
| Pretax Margin | 16.4% | 16.4% | 14.7% | 17.4% | 22.6% | 22.4% | 15.9% | 13.4% | · | 11.1% | 11.4% | |
| EBITDA Margin | 17.4% | 17.1% | 16.0% | 18.7% | 25.6% | 24.2% | 18.0% | 24.8% | · | 23.0% | 23.7% | |
| ROA | 6.5% | 6.4% | 6.1% | 7.2% | 9.4% | · | · | · | · | · | · | |
| ROE | 13.0% | 13.2% | 13.1% | 16.4% | 19.9% | · | · | · | · | · | · | |
| ROIC | 13.4% | 13.4% | 14.0% | 17.4% | 21.5% | 12.8% | 8.9% | 12.0% | · | 10.9% | 11.2% |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.7 | 1.8 | 1.5 | 1.5 | 2.1 | 1.9 | 1.7 | · | 1.4 | 1.4 | |
| Quick Ratio | 1.3 | 1.0 | 1.2 | 1.0 | 0.9 | 1.6 | 1.1 | 1.0 | · | 0.8 | 0.7 | |
| Debt / Equity | · | · | · | · | · | 0.6 | 0.6 | 0.0 | · | 0.0 | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | 0.6 | 0.6 | · | · | · | · | |
| Interest Coverage | · | · | 5.0 | 11.6 | 18.7 | 14.1 | 6.8 | 5.7 | · | 5.2 | 5.6 |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | · | 0.4 | 0.4 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | 3.9 | 3.9 | |
| Receivables Turnover | 5.2 | 5.2 | 5.2 | 5.6 | 5.7 | 6.4 | 6.0 | 6.1 | · | 6.5 | 6.8 |
Wachstumsraten 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 3.9% | 0.05% | -4.6% | 14.5% | 21.7% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -0.27% | 3.0% | 10.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.7% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 7.3% | 7.0% | -12.4% | -9.4% | 21.9% | · | · | · | · | · | · | |
| EPS CAGR 3Y | 0.21% | -5.3% | -1.1% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 2.1% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 5.8% | 5.7% | -13.9% | -9.9% | 21.2% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -1.2% | -6.4% | -2.0% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 1.0% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 13.5% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.56B | $42.88B | $42.86B | $44.91B | $39.21B | $32.22B | $25.54B | $24.36B | · | $18.27B | $16.96B | |
| Net Income TTM | $6.70B | $6.33B | $6.00B | $6.96B | $7.73B | $6.38B | $3.70B | $1.48B | · | $1.48B | $1.48B | |
| Market Cap | $257.86B | $230.98B | $234.61B | $242.85B | · | · | · | · | · | · | · | |
| P/E | 32.7 | 31.5 | 34.4 | 31.2 | 34.3 | 29.2 | 35.4 | 30.9 | · | 27.7 | 28.8 | |
| P/S | 5.8 | 5.4 | 5.5 | 5.4 | · | · | · | · | · | · | · | |
| P/B | 4.8 | 4.7 | 5.0 | 5.5 | · | · | · | · | · | · | · | |
| P / Cash Flow | 33.0 | 26.7 | 27.9 | 26.5 | · | · | · | · | · | · | · | |
| P / FCF | 41.0 | 31.8 | 33.9 | 35.1 | · | · | · | · | · | · | · | |
| Dividend Yield | 0.25% | 0.25% | 0.22% | 0.19% | · | · | · | · | · | · | · | |
| Earnings Yield | 3.1% | 3.2% | 2.9% | 3.2% | 2.9% | 3.4% | 2.8% | 3.2% | · | 3.6% | 3.5% | |
| Payout Ratio | 9.5% | 9.2% | 8.8% | 6.5% | 5.1% | · | · | · | · | · | · | |
| Annual Payout | $636M | $583M | $523M | $455M | $395M | $337M | $297M | $266M | · | $238M | $241M |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.99B | $11.01B | $12.21B | $11.12B | $10.86B | $10.36B | $11.39B | $10.60B | $10.54B | $10.35B | $10.89B | $10.57B | $10.71B | $11.45B | |
| R&D Expense | $364M | $336M | $357M | $346M | $352M | $342M | $374M | $346M | $339M | $331M | $327M | $319M | $346M | $391M | |
| SG&A Expense | $2.33B | $2.18B | $2.35B | $2.16B | $2.14B | $2.08B | $2.20B | $2.10B | $2.11B | $2.18B | $2.13B | $2.05B | $2.12B | $2.30B | |
| Operating Expenses | $9.91B | $9.14B | $9.96B | $9.18B | $9.02B | $8.65B | $9.38B | $8.76B | $8.72B | $8.68B | $9.03B | $8.71B | $9.15B | $9.59B | |
| Operating Income | $2.09B | $1.86B | $2.25B | $1.94B | $1.83B | $1.72B | $2.02B | $1.84B | $1.82B | $1.66B | $1.85B | $1.86B | $1.56B | $1.86B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $363M | · | $359M | $300M | · | |
| Interest Income | $207M | $233M | $259M | $234M | $297M | $203M | $227M | $277M | $295M | $279M | $309M | $246M | $146M | $150M | |
| Other Non-op | $31M | $-9M | $6M | $-2M | $-19M | $3M | $13M | $-16M | $5M | $10M | $-33M | $14M | $-46M | $35M | |
| Pretax Income | $1.92B | $1.73B | $2.15B | $1.83B | $1.71B | $1.62B | $1.94B | $1.74B | $1.76B | $1.59B | $1.74B | $1.76B | $1.36B | $1.78B | |
| Income Tax | $167M | $70M | $153M | $207M | $92M | $95M | $149M | $99M | $128M | $281M | $133M | $53M | $46M | $173M | |
| Net Income | $1.74B | $1.65B | $1.96B | $1.62B | $1.62B | $1.51B | $1.83B | $1.63B | $1.55B | $1.33B | $1.65B | $1.70B | $1.29B | $1.57B | |
| EPS (Basic) | $4.68 | $4.44 | $5.22 | $4.28 | $4.28 | $3.99 | $4.80 | $4.26 | $4.05 | $3.47 | $4.21 | $4.44 | $3.34 | $4.03 | |
| EPS (Diluted) | $4.68 | $4.43 | $5.21 | $4.27 | $4.28 | $3.98 | $4.78 | $4.25 | $4.04 | $3.46 | $4.20 | $4.42 | $3.32 | $4.01 | |
| Shares (Basic) | 371,000,000 | 372,000,000 | -757,000,000 | 378,000,000 | 378,000,000 | 378,000,000 | -764,000,000 | 382,000,000 | 382,000,000 | 382,000,000 | 0 | 386,000,000 | 386,000,000 | 0 | |
| Shares (Diluted) | 371,000,000 | 373,000,000 | -757,000,000 | 378,000,000 | 378,000,000 | 379,000,000 | -768,000,000 | 384,000,000 | 383,000,000 | 384,000,000 | 0 | 388,000,000 | 388,000,000 | -1,000,000 | |
| EBITDA | $2.09B | $1.86B | · | $1.94B | $1.83B | $1.72B | · | $1.84B | $1.82B | $1.66B | · | $1.86B | $1.56B | · |
Bilanz 26
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.06B | $3.25B | $9.85B | $1.98B | $4.58B | $4.13B | $4.01B | $4.64B | $7.07B | $5.50B | · | $6.15B | $3.48B | · | |
| Short-term Investments | $0 | $2M | $253M | $1.56B | $1.81B | $1.81B | $1.56B | $2.00B | $1.75B | $1.75B | · | · | · | · | |
| Receivables | $9.45B | $9.20B | $8.90B | $8.91B | $8.59B | $8.46B | $8.19B | $8.26B | $7.94B | $7.93B | · | $8.37B | $7.92B | · | |
| Inventory | $5.63B | $5.50B | $5.42B | $5.75B | $5.56B | $5.22B | $4.98B | $5.43B | $5.20B | $5.13B | · | $5.40B | $5.66B | · | |
| Other Current Assets | $2.54B | $2.68B | $2.61B | $2.47B | $2.60B | $2.39B | $1.96B | $1.91B | $2.02B | $1.90B | · | $1.70B | $1.77B | · | |
| Current Assets | $23.36B | $22.32B | $28.71B | $22.30B | $24.58B | $23.38B | $22.14B | $23.78B | $25.48B | $23.64B | · | $23.09B | $20.21B | · | |
| PP&E (Net) | $10.76B | $10.66B | $10.56B | $10.18B | $9.63B | $9.33B | $9.31B | $9.41B | $9.28B | $9.32B | · | $9.17B | $9.35B | · | |
| PP&E (Gross) | · | · | $18.38B | · | · | · | $16.06B | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $7.82B | · | · | · | $6.75B | · | · | · | · | · | · | · | |
| Goodwill | $54.83B | $55.19B | $49.36B | $49.29B | $47.25B | $46.49B | $45.85B | $46.73B | $43.84B | $43.84B | $44.02B | $43.58B | $43.14B | $41.20B | |
| Intangibles | $18.61B | $19.15B | $15.84B | $16.24B | $15.15B | $15.32B | $15.53B | $16.26B | $15.52B | $16.05B | · | $17.09B | $17.97B | · | |
| Other Non-current Assets | $5.62B | $5.97B | $5.87B | $5.02B | $4.62B | $4.52B | $4.49B | $4.18B | $4.38B | $4.24B | · | $4.12B | $3.98B | · | |
| Total Assets | $113.17B | $113.28B | $110.34B | $103.02B | $101.23B | $99.04B | $97.32B | $100.36B | $98.50B | $97.09B | $98.73B | $97.06B | $94.66B | $97.15B | |
| Accounts Payable | $3.27B | $3.34B | $3.62B | $3.12B | $2.98B | $3.05B | $3.08B | $2.61B | $2.55B | $2.56B | · | $2.51B | $2.80B | · | |
| Current Liabilities | $15.07B | $14.62B | $15.19B | $14.89B | $12.72B | $13.17B | $13.33B | $14.60B | $14.77B | $13.94B | · | $14.16B | $15.88B | · | |
| Capital Leases | · | · | $1.20B | · | · | · | $1.24B | · | · | · | · | · | · | · | |
| Deferred Tax | $1.58B | $2.11B | $1.49B | $842M | $624M | $1.04B | $1.27B | $1.12B | $1.52B | $1.81B | · | $2.62B | $2.98B | · | |
| Other Non-current Liabilities | $4.54B | $4.42B | $4.27B | $4.28B | $4.27B | $3.97B | $3.99B | $4.34B | $4.39B | $4.57B | · | $4.33B | $4.23B | · | |
| Long-term Debt | $42.28B | $42.95B | $39.17B | $35.48B | $35.03B | $33.99B | $31.07B | $35.11B | $35.20B | $35.39B | · | $35.08B | $35.05B | · | |
| Common Stock | $446M | $445M | $445M | $445M | $444M | $444M | $444M | $444M | $443M | $443M | · | $442M | $441M | · | |
| Retained Earnings | $62.19B | $60.63B | $59.16B | $57.35B | $55.90B | $54.45B | $53.10B | $51.42B | $49.94B | $48.54B | · | $45.87B | $43.06B | · | |
| Treasury Stock | $26.37B | $25.36B | $22.31B | $22.31B | $21.27B | $21.27B | $19.23B | $18.23B | $18.19B | $18.19B | · | $15.12B | $15.08B | · | |
| AOCI | $-2.46B | $-2.50B | $-2.45B | $-2.80B | $-2.80B | $-2.34B | $-2.70B | $-2.48B | $-2.41B | $-2.76B | · | $-3.03B | $-3.05B | · | |
| Stockholders' Equity | $52.68B | $51.93B | $53.41B | $51.02B | $50.51B | $49.39B | $49.58B | $48.99B | $47.43B | $45.52B | · | $45.33B | $42.26B | · | |
| Liabilities + Equity | $113.17B | $113.28B | $110.34B | $103.02B | $101.23B | $99.04B | $97.32B | $100.36B | $98.50B | $97.09B | · | $97.06B | $94.66B | · | |
| Shares Outstanding | 446,000,000 | 445,000,000 | 445,000,000 | 445,000,000 | 444,000,000 | 444,000,000 | 444,000,000 | 444,000,000 | 443,000,000 | 443,000,000 | 442,000,000 | 442,000,000 | 441,000,000 | 441,000,000 |
Cashflow 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $82M | $83M | $84M | $70M | $81M | $75M | $79M | $68M | $84M | $70M | $61M | $67M | $76M | $75M | |
| Deferred Tax | $-208M | $-258M | $89M | $-127M | $-322M | $-279M | $-202M | $-400M | · | · | · | · | · | · | |
| Amort. of Intangibles | $485M | $430M | $436M | $435M | $430M | $429M | $438M | $449M | $514M | $551M | $563M | $584M | $606M | $592M | |
| Restructuring | $38M | $34M | $36M | $62M | $56M | $43M | $20M | $26M | $26M | $25M | $19M | $38M | $50M | $37M | |
| Operating Cash Flow | $2.12B | $1.19B | $3.46B | $2.24B | $1.40B | $723M | $3.29B | $2.17B | $1.96B | $1.25B | $3.72B | $2.41B | $729M | $3.49B | |
| CapEx | $450M | $376M | $465M | $404M | $294M | $362M | $480M | $272M | $301M | $347M | $405M | $332M | $458M | $550M | |
| Investing Cash Flow | $164M | $-8.96B | $891M | $-4.12B | $-288M | $-527M | $20M | $-3.58B | $-253M | $-2.03B | $-376M | $-1.18B | $-3.14B | $-525M | |
| Debt Issued | $0 | $5.24B | $4.92B | $0 | $0 | $2.84B | $0 | $0 | $-1M | $1.21B | $2.48B | $3.47B | $0 | $3.19B | |
| Net Debt Issued | · | $3.83B | · | · | · | $2.00B | · | · | · | $1.21B | · | · | $0 | · | |
| Stock Repurchased | $1.00B | $3.00B | $37M | $963M | $0 | $2.00B | $1.00B | $0 | $0 | $3.00B | $0 | $0 | $3.00B | $1.00B | |
| Net Stock Activity | · | $-3.00B | · | · | · | $-2.00B | · | · | · | $-3.00B | · | · | $-3.00B | · | |
| Dividends Paid | $175M | $162M | $162M | $163M | $162M | $149M | $149M | $150M | $149M | $135M | $136M | $135M | $117M | $117M | |
| Financing Cash Flow | $-1.57B | $1.09B | $3.53B | $-632M | $-991M | $-102M | $-3.67B | $-1.19B | $-115M | $-1.82B | $-1.43B | $1.85B | $-2.59B | $2.39B | |
| Net Change in Cash | $817M | $-6.60B | $7.87B | $-2.59B | $431M | $132M | $-630M | $-2.43B | $1.58B | $-2.58B | $1.93B | $3.02B | $-5.04B | $5.60B | |
| Free Cash Flow | · | $816M | · | · | · | $361M | · | · | · | $904M | · | · | $271M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $605M | · | · | $-19M | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 17.4% | 16.9% | · | 17.4% | 16.9% | 16.6% | · | 17.3% | 17.3% | 16.1% | · | 17.6% | 14.6% | · | |
| Net Margin | 14.5% | 15.0% | · | 14.5% | 14.9% | 14.6% | · | 15.4% | 14.7% | 12.9% | · | 16.0% | 12.1% | · | |
| Pretax Margin | 16.0% | 15.8% | · | 16.4% | 15.7% | 15.6% | · | 16.4% | 16.7% | 15.4% | · | 16.7% | 12.7% | · | |
| EBITDA Margin | 17.4% | 16.9% | · | 17.4% | 16.9% | 16.6% | · | 17.3% | 17.3% | 16.1% | · | 17.6% | 14.6% | · | |
| ROA | 1.6% | 1.6% | · | 1.6% | 1.6% | 1.5% | · | 1.7% | 1.6% | 1.4% | · | 1.8% | · | · | |
| ROE | 3.4% | 3.3% | · | 3.2% | 3.3% | 3.2% | · | 3.5% | 3.4% | 3.0% | · | 3.8% | · | · | |
| ROIC | 3.6% | 3.4% | · | 3.4% | 3.4% | 3.3% | · | 3.5% | 3.6% | 3.0% | · | 4.0% | · | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.5 | · | 1.5 | 1.9 | 1.8 | · | 1.6 | 1.7 | 1.7 | · | 1.6 | · | · | |
| Quick Ratio | 0.9 | 0.9 | · | 0.8 | 1.2 | 1.1 | · | 1.0 | 1.1 | 1.1 | · | 1.0 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 4.6 | · | 5.2 | 5.2 | · |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | · | · | |
| Receivables Turnover | 1.3 | 1.2 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.98B | $43.35B | · | $42.94B | $42.36B | $41.85B | · | $42.06B | $42.15B | $42.32B | · | $42.65B | $44.17B | · | |
| Net Income TTM | $6.62B | $6.39B | · | $6.37B | $6.31B | $6.02B | · | $6.20B | $5.94B | $5.68B | · | $5.85B | $6.68B | · | |
| Market Cap | $228.81B | $210.65B | · | $206.59B | $181.28B | $222.07B | · | $272.80B | $244.98B | $257.48B | · | $223.73B | · | · | |
| P/E | 29.1 | 27.9 | · | 27.7 | 24.7 | 31.8 | · | 38.0 | 35.8 | 39.5 | · | 33.7 | 34.0 | · | |
| P/S | 5.1 | 4.9 | · | 4.8 | 4.3 | 5.3 | · | 6.5 | 5.8 | 6.1 | · | 5.2 | · | · | |
| P/B | 4.3 | 4.1 | · | 4.0 | 3.6 | 4.5 | · | 5.6 | 5.2 | 5.7 | · | 4.9 | · | · | |
| P / Cash Flow | · | 176.7 | · | · | · | 307.2 | · | · | · | 205.8 | · | · | · | · | |
| P / FCF | · | 258.1 | · | · | · | 615.2 | · | · | · | 284.8 | · | · | · | · | |
| Earnings Yield | 3.4% | 3.6% | · | 3.6% | 4.0% | 3.1% | · | 2.6% | 2.8% | 2.5% | · | 3.0% | 2.9% | · | |
| Payout Ratio | · | 9.8% | · | · | · | 9.9% | · | · | · | 10.1% | · | · | 9.1% | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2025-06-28 | 2025-03-29 | 2024-12-31 | 2024-09-28 | |
|---|---|---|---|---|---|
| Umsatz | $44.56B | — | — | $42.88B | — |
| Betriebsgewinnmarge % | 17.4% | — | — | 17.1% | — |
| Nettoergebnis | $6.70B | — | — | $6.33B | — |
| Verwässerte EPS | $17.74 | — | — | $16.53 | — |
Bilanz
| 2025-12-31 | 2025-06-28 | 2025-03-29 | 2024-12-31 | 2024-09-28 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 1.9 | — | — | 1.7 | — |
| Quick Ratio | 1.3 | — | — | 1.0 | — |
Cashflow
| 2025-12-31 | 2025-06-28 | 2025-03-29 | 2024-12-31 | 2024-09-28 | |
|---|---|---|---|---|---|
| Freier Cashflow | $6.29B | — | — | $7.27B | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
- Analysts Appear Bullish on Thermo Fisher (TMO): Is The Stock Really a Buy After Earnings?
- Mögen Wall Street Analysten Thermo Fisher Scientific Aktien?
- Thermo Fisher Scientific Inc. (TMO) enthüllt Bioprozess-Designzentrum zur Entwicklung lebensverändernder Therapien
- Jim Cramer über Thermo Fisher: „Ich denke, Sie können es bei diesem Kurs kaufen“
- TD Cowen Senkt das Kursziel für Thermo Fisher (TMO), behält Kaufempfehlung bei
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 2.903 Einreicher · $107.5B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 196 (-6 vs. Vorquartal) | 140 (-78 vs. Vorquartal) | 925 (-41 vs. Vorquartal) | 1.116 (+29 vs. Vorquartal) | +59.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $12.171.173.789 | 24.276.316 | 11,32% | Aktien |
| STATE STREET CORP | $8.443.627.719 | 16.825.879 | 7,85% | Aktien |
| FMR LLC | $4.526.822.682 | 9.029.086 | 4,21% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $3.572.029.397 | 7.164.352 | 3,32% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.121.552.090 | 6.226.169 | 2,90% | Aktien |
| Capital World Investors | $3.106.193.041 | 6.195.370 | 2,89% | Aktien |
| NORGES BANK | $2.550.871.048 | 5.087.903 | 2,37% | Aktien |
| Capital Research Global Investors | $2.079.461.815 | 4.147.545 | 1,93% | Aktien |
| Capital International Investors | $1.595.416.232 | 3.182.151 | 1,48% | Aktien |
| Dodge & Cox | $1.531.543.498 | 3.054.778 | 1,42% | Aktien |
| Fisher Asset Management, LLC | $1.461.823.432 | 2.915.715 | 1,36% | Aktien |
| Grantham, Mayo, Van Otterloo & Co. LLC | $1.373.321.891 | 2.739.191 | 1,28% | Aktien |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $1.371.130.859 | 2.734.823 | 1,28% | Aktien |
| EdgePoint Investment Group Inc. | $1.092.789.324 | 2.179.650 | 1,02% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.046.130.256 | 2.086.585 | 0,97% | Aktien |
| Unisphere Establishment | $1.032.801.600 | 2.060.000 | 0,96% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $1.009.204.590 | 2.012.934 | 0,94% | Aktien |
| PRIMECAP MANAGEMENT CO/CA/ | $993.831.390 | 1.982.271 | 0,92% | Aktien |
| VIKING GLOBAL INVESTORS LP | $971.342.384 | 1.937.415 | 0,90% | Aktien |
| FLOSSBACH VON STORCH SE | $955.579.626 | 1.905.975 | 0,89% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $908.857.157 | 1.849.037 | 0,85% | Aktien |
| 1832 Asset Management L.P. | $863.062.662 | 1.721.443 | 0,80% | Aktien |
| Clearbridge Investments, LLC | $847.834.531 | 1.691.069 | 0,79% | Aktien |
| PARNASSUS INVESTMENTS, LLC | $822.024.341 | 1.639.589 | 0,76% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $768.919.799 | 1.533.667 | 0,72% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $667.185.605 | 1.330.750 | 0,62% | Aktien |
| Temasek Holdings (Private) Ltd | $583.447.171 | 1.163.729 | 0,54% | Aktien |
| BlackRock, Inc. | $579.344.543 | 1.155.546 | 0,54% | Aktien |
| LOOMIS SAYLES & CO L P | $571.001.278 | 1.138.905 | 0,53% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $567.301.499 | 1.131.525 | 0,53% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $541.170.491 | 1.079.405 | 0,50% | Aktien |
| Pictet Asset Management Holding SA | $538.406.962 | 1.073.670 | 0,50% | Aktien |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $526.019.392 | 1.049.185 | 0,49% | Aktien |
| Swiss National Bank | $525.485.443 | 1.048.120 | 0,49% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $505.067.056 | 1.007.394 | 0,47% | Aktien |
| Rathbones Group PLC | $504.097.425 | 1.005.460 | 0,47% | Aktien |
| UBS Group AG | $503.596.066 | 1.004.460 | 0,47% | Aktien |
| BANK OF AMERICA CORP /DE/ | $488.690.042 | 974.729 | 0,45% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $450.916.165 | 899.386 | 0,42% | Aktien |
| Veritas Asset Management LLP | $442.637.207 | 882.873 | 0,41% | Aktien |
| Focus Partners Wealth | $431.444.332 | 860.536 | 0,40% | Aktien |
| FIRST MANHATTAN CO. LLC. | $422.447.886 | 841.894 | 0,39% | Aktien |
| National Pension Service | $422.118.548 | 841.947 | 0,39% | Aktien |
| GOLDMAN SACHS GROUP INC | $417.251.345 | 832.239 | 0,39% | Aktien |
| D1 Capital Partners L.P. | $409.672.787 | 817.123 | 0,38% | Aktien |
| W1M Asset Management Ltd | $408.009.352 | 814.886 | 0,38% | Aktien |
| Vanguard Global Advisers, LLC | $401.921.762 | 801.663 | 0,37% | Aktien |
| Legal & General Group Plc | $393.992.751 | 785.848 | 0,37% | Aktien |
| BARCLAYS PLC | $383.005.951 | 763.934 | 0,36% | Aktien |
| AMERIPRISE FINANCIAL INC | $373.268.191 | 744.431 | 0,35% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $369.918.950 | 737.831 | 0,34% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $365.892.528 | 729.800 | 0,34% | Aktien |
| VANGUARD GROUP INC | $354.408.424 | 611.629 | 0,33% | Aktien |
| California Public Employees Retirement System | $349.327.092 | 696.759 | 0,32% | Aktien |
| KING LUTHER CAPITAL MANAGEMENT CORP | $339.577.646 | 677.313 | 0,32% | Aktien |
| W1M Investment Management Ltd | $335.034.706 | 691.342 | 0,31% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $321.963.477 | 642.176 | 0,30% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $319.519.265 | 637.305 | 0,30% | Aktien |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $314.473.046 | 627.240 | 0,29% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $309.344.243 | 616.961 | 0,29% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $307.944.336 | 614.218 | 0,29% | Aktien |
| D. E. Shaw & Co., Inc. | $307.017.322 | 612.369 | 0,29% | Aktien |
| JANUS HENDERSON GROUP PLC | $301.030.667 | 612.436 | 0,28% | Aktien |
| RHUMBLINE ADVISERS | $297.780.694 | 593.946 | 0,28% | Aktien |
| Ninety One UK Ltd | $297.641.362 | 593.668 | 0,28% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $296.956.107 | 592.301 | 0,28% | Aktien |
| Mirova US LLC | $296.432.610 | 591.257 | 0,28% | Aktien |
| Robeco Institutional Asset Management B.V. | $289.599.072 | 577.627 | 0,27% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $281.062.261 | 571.811 | 0,26% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $274.562.786 | 547.636 | 0,26% | Aktien |
| Eurizon Capital SGR S.p.A. | $271.488.657 | 539.965 | 0,25% | Aktien |
| APG Asset Management N.V. | $266.543.464 | 607.825 | 0,25% | Aktien |
| Longview Partners (Guernsey) LTD | $265.608.495 | 529.776 | 0,25% | Aktien |
| CITADEL ADVISORS LLC | $263.486.238 | 525.543 | 0,25% | Aktien |
| Lindsell Train Ltd | $257.955.736 | 514.512 | 0,24% | Aktien |
| Southpoint Capital Advisors LP | $250.680.000 | 500.000 | 0,23% | Aktien |
| Qube Research & Technologies Ltd | $246.959.909 | 492.580 | 0,23% | Aktien |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | $245.733.399 | 490.134 | 0,23% | Aktien |
| CI INVESTMENTS INC. | $235.771.058 | 470.263 | 0,22% | Aktien |
| Balyasny Asset Management L.P. | $225.425.494 | 449.628 | 0,21% | Aktien |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | $223.014.454 | 444.819 | 0,21% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $221.174.247 | 431.114 | 0,21% | Aktien |
| ROYAL LONDON ASSET MANAGEMENT LTD | $217.246.307 | 433.314 | 0,20% | Aktien |
| M&G PLC | $214.820.283 | 428.783 | 0,20% | Aktien |
| Liontrust Investment Partners LLP | $211.478.390 | 364.964 | 0,20% | Aktien |
| Cryder Capital Partners LLP | $210.160.586 | 419.181 | 0,20% | Aktien |
| FIFTH THIRD BANCORP | $209.624.364 | 418.112 | 0,19% | Aktien |
| JANE STREET GROUP, LLC | $205.206.648 | 409.300 | 0,19% | Verkaufsoption |
| JANE STREET GROUP, LLC | $204.905.832 | 408.700 | 0,19% | Kaufoption |
| Ensign Peak Advisors, Inc | $204.085.607 | 407.064 | 0,19% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $203.978.817 | 406.851 | 0,19% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $203.629.369 | 406.154 | 0,19% | Aktien |
| AVIVA PLC | $202.744.469 | 404.389 | 0,19% | Aktien |
| Navera Investment Management Ltd. | $199.087.273 | 397.439 | 0,19% | Aktien |
| FIL Ltd | $198.044.720 | 395.015 | 0,18% | Aktien |
| CIBC Bancorp USA Inc. | $190.068.606 | 378.891 | 0,18% | Aktien |
| Alyeska Investment Group, L.P. | $188.546.957 | 376.071 | 0,18% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $187.568.351 | 373.510 | 0,17% | Aktien |
| Liontrust Investment Partners LLP | $181.599.110 | 362.213 | 0,17% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $180.518.000 | 360.056 | 0,17% | Aktien |
Unternehmensinsider 60 Insider · 29 Führungskräfte · 28 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Marijn E Dekkers | Chief Executive Officer | 17. August 2009 F | 42.554 | 0 | 0 | $0 |
| Stephen Williamson | Retiring Sr. VP and CFO | 28. Februar 2026 F | 32.499 | 0 | 0 | $0 |
| Kyriazi Theo Melas | VP & Chief Financial Officer | 16. September 2004 M | 158.199 | 0 | 0 | $0 |
| Gianluca Pettiti | President & COO | 27. Juli 2026 S | 24.651 | 0 | 6 | $-2.582.704 |
| Mark Stevenson | Retiring Executive VP & COO | 25. Februar 2022 F | 62.141 | 0 | 0 | $0 |
| Frederick M. Lowery | Executive Vice President | 28. Februar 2026 F | 15.044 | 0 | 2 | $-8.154.131 |
| Michel Lagarde | Executive Vice President | 28. Februar 2026 F | 85.151 | 0 | 5 | $-51.307.290 |
| Thomas B Shropshire Jr. | SVP and General Counsel | 25. Februar 2026 A | 6.058 | 0 | 0 | $0 |
| Michael A Boxer | SVP and General Counsel | 10. März 2025 S | 10.816 | 0 | 0 | $0 |
| Syed A. Jafry | Sr. Vice President | 26. Februar 2021 F | 22.349 | 0 | 0 | $0 |
| Peter E Hornstra | VP & Chief Accounting Officer | 26. Februar 2021 F | 1.962 | 0 | 0 | $0 |
| Patrick M Durbin | Senior Vice President | 28. August 2019 F | 38.868 | 0 | 0 | $0 |
| Gregory J. Herrema | Senior Vice President | 28. August 2019 F | 26.967 | 0 | 0 | $0 |
| Seth H Hoogasian | Sr. VP & Retiring Gen. Counsel | 28. Februar 2018 F | 26.530 | 0 | 0 | $0 |
| Shine Daniel P | Senior Vice President | 30. August 2017 S | 20.682 | 0 | 0 | $0 |
| Thomas W Loewald | Senior Vice President | 28. August 2017 F | 38.133 | 0 | 0 | $0 |
| Peter M Wilver | Exec. VP & Chief Admin Officer | 15. März 2017 S | 62.517 | 0 | 0 | $0 |
| Alan J Malus | Executive Vice President | 10. März 2016 M | 47.286 | 0 | 0 | $0 |
| Andrew J Thomson | Senior Vice President | 26. August 2015 F | 52.389 | 0 | 0 | $0 |
| Edward A Pesicka | Senior Vice President | 5. März 2015 M | 80.641 | 0 | 0 | $0 |
| Kenneth Berger | Senior Vice President | 26. Februar 2012 F | 36.128 | 0 | 0 | $0 |
| Stephen G Sheehan | Sr. VP, Human Resources | 5. März 2010 F | 4.396 | 0 | 0 | $0 |
| Yuh-Geng Tsay | Senior Vice President | 26. Februar 2010 F | 110.369 | 0 | 0 | $0 |
| Alexander G Stachtiaris | Sr. VP, Global Bus. Services | 5. März 2008 A | 17.236 | 0 | 0 | $0 |
| Fredric T Walder | Sr. VP, Customer Excellence | 5. März 2008 A | 16.730 | 0 | 0 | $0 |
| Guy Broadbent | Senior Vice President | 5. März 2008 A | 31.545 | 0 | 0 | $0 |
| Joseph R Massaro | Sr. VP, Global Bus. Services | 16. November 2007 S | 15.000 | 0 | 0 | $0 |
| SYRON RICHARD F/CA | Executive Chairman | 12. Dezember 2003 S | 80.320 | 0 | 0 | $0 |
| Barry S Howe | VP, Measurement & Control | 31. Juli 2003 M | 23.247 | 0 | 0 | $0 |
| Alexandra R. Keith | Direktor | 27. Juni 2026 A | 2.602 | 0 | 0 | $0 |
| Dion J Weisler | Direktor | 27. Juni 2026 A | 5.446 | 0 | 0 | $0 |
| Karen S Lynch | Direktor | 27. Juni 2026 A | 1.159 | 0 | 0 | $0 |
| Scott M Sperling | Direktor | 27. Juni 2026 A | 69.479 | 0 | 0 | $0 |
| Jennifer M Johnson | Direktor | 27. Juni 2026 A | 1.403 | 0 | 0 | $0 |
| Debora L Spar | Direktor | 20. Mai 2026 A | 2.610 | 0 | 0 | $0 |
| Tyler Jacks | Direktor | 20. Mai 2026 A | 9.462 | 0 | 0 | $0 |
| Ruby R Chandy | Direktor | 20. Mai 2026 A | 3.463 | 0 | 0 | $0 |
| Nelson Chai | Direktor | 20. Mai 2026 A | 15.316 | 0 | 0 | $0 |
| Martin C Harris | Direktor | 20. Mai 2026 A | 9.532 | 0 | 0 | $0 |
| MULLEN JAMES C | Direktor | 21. Mai 2025 A | 3.393 | 0 | 0 | $0 |
| Lars Rebien Sorensen | Direktor | 22. Mai 2024 F | 9.233 | 0 | 0 | $0 |
| Jim P Manzi | Direktor | 3. Februar 2023 S | 14.807 | 0 | 0 | $0 |
| Thomas J Lynch | Direktor | 5. November 2021 G | 10.257 | 0 | 0 | $0 |
| Judy C Lewent | Direktor | 20. Mai 2020 A | 1.290 | 0 | 0 | $0 |
| Elaine Ullian | Direktor | 22. Mai 2019 A | 4.706 | 0 | 0 | $0 |
| William G Parrett | Direktor | 23. Februar 2018 S | 11.660 | 0 | 0 | $0 |
| Michael E Porter | Direktor | 9. März 2012 M | 14.640 | 0 | 0 | $0 |
| Peter J Manning | Direktor | 25. Mai 2011 A | 6.548 | 0 | 0 | $0 |
| Michael Adam Bell | Direktor | 20. Mai 2010 A | 8.192 | 0 | 0 | $0 |
| Stephen P Kaufman | Direktor | 20. Mai 2010 A | 9.192 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 22 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Pharmaceutical Product Development, LLC, Wildcat Acquisition Holdings (UK) Limited, Jaguar Holding Company II, Jaguar Holding Company I, LLC, Eagle Holding Company II, LLC, PPD, Inc., Thermo Fisher Scientific Powder US Holdings Corp., Thermo Fisher Scientific Inc., Fisher Scientific International LLC, Fisher Scientific Worldwide Inc., Spectra-Physics Holdings USA, LLC, Thermo Fisher Scientific Powder Holdings I Ltd, Thermo Fisher Scientific Powder Holdings II Ltd, Thermo Fisher Scientific Powder Holdings III Ltd, Thermo Fisher Scientific Powder Holdings IV Ltd, Thermo Fisher Scientific Powder US Holdings Ltd ×2 Einreichungen | 14. März 2024 | — | Erste Einreichung | M&A / Verkauf | SEC |
| Thermo Fisher Scientific Inc., Thermo Fisher (CN) Luxembourg S.à r.l. ×2 Einreichungen | 13. September 2017 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 30. Juni 2005 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 11. Mai 2005 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 24. März 2005 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 2. März 2005 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 28. Juli 2004 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 27. Juli 2004 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 28. Oktober 2003 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 17. Oktober 2002 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 16. Oktober 2002 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 4. April 2002 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 1. April 2002 | — | Erste Einreichung | — | SEC |
| Thermo Electron Corporation IRS No. ×5 Einreichungen | 27. Dezember 2001 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 21. November 2001 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 213 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| GDOC · Goldman Sachs ETF Trust | 4,52% | 1.847 NS | 31. Mai 2026 | N-PORT |
| AGIQ · Tidal Trust I | 3,99% | 918 NS | 31. Mai 2026 | N-PORT |
| HRTS · Tema ETF Trust | 3,97% | 4.185 NS | 31. Mai 2026 | N-PORT |
| IYH · iShares Trust | 3,51% | 222.608 SH | 8. August 2026 | Täglich |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 3,19% | 740 NS | 30. April 2026 | N-PORT |
| PRVS · Parnassus Funds II | 3,12% | 1.576 NS | 30. Juni 2026 | N-PORT |
| QLTY · GMO ETF Trust | 2,94% | 269.227 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 2,91% | 173.204 NS | 30. April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 2,74% | 1.117.168 SH | 8. August 2026 | Täglich |
| IXJ · iShares Trust | 2,72% | 195.170 SH | 8. August 2026 | Täglich |
| RXL · ProShares Trust | 2,68% | 3.918 NS | 31. Mai 2026 | N-PORT |
| EQTY · Valued Advisers Trust | 2,66% | 72.927 NS | 30. April 2026 | N-PORT |
| TOLL · Tema ETF Trust | 2,63% | 2.616 NS | 31. Mai 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 2,59% | 7.491 NS | 30. April 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 2,39% | 1.916 NS | 30. April 2026 | N-PORT |
| KAT · Advisors Series Trust | 2,24% | 30.779 NS | 31. März 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,99% | 2.213 NS | 30. April 2026 | N-PORT |
| CAML · Professionally Managed Portfolios | 1,88% | 14.779 NS | 30. April 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,86% | 24.566 SH | 8. August 2026 | Täglich |
| PEXL · Pacer Funds Trust | 1,67% | 1.592 NS | 30. April 2026 | N-PORT |
| FMCE · Northern Lights Fund Trust IV | 1,64% | 2.250 NS | 31. Mai 2026 | N-PORT |
| FMCX · Northern Lights Fund Trust IV | 1,63% | 3.902 NS | 31. Mai 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,53% | 1.276 NS | 31. Mai 2026 | N-PORT |
| BKDV · BNY Mellon ETF Trust II | 1,43% | 41.397 NS | 30. April 2026 | N-PORT |
| GKAT · Advisors Series Trust | 1,41% | 4.289 NS | 31. März 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 1,32% | 1.154 NS | 30. April 2026 | N-PORT |
| SNPV · DBX ETF Trust | 1,26% | 5.900 NS | 29. Mai 2026 | N-PORT |
| ALRG · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 1,22% | 189 NS | 30. April 2026 | N-PORT |
| LRGC · AB Active ETFs, Inc. | 1,20% | 30.508 NS | 31. Mai 2026 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 1,16% | 54.333 SH | 8. August 2026 | Täglich |
| MFSG · MFS Active Exchange Traded Funds Tr… | 1,16% | 8.091 NS | 31. Mai 2026 | N-PORT |
| RFFC · ALPS ETF Trust | 1,08% | 654 NS | 31. Mai 2026 | N-PORT |
| FBCV · FIDELITY COVINGTON TRUST | 1,02% | 3.416 NS | 30. April 2026 | N-PORT |
| FFND · Northern Lights Fund Trust II | 1,02% | 2.122 NS | 31. Mai 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 0,88% | 233.578 SH | 8. August 2026 | Täglich |
| CAPE · DoubleLine ETF Trust | 0,86% | 4.580 NS | 31. März 2026 | N-PORT |
| CRTC · DBX ETF Trust | 0,85% | 2.247 NS | 31. Mai 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,84% | 15.398 NS | 30. April 2026 | N-PORT |
| USXF · iShares Trust | 0,84% | 21.650 SH | 8. August 2026 | Täglich |
| BSCQ · Invesco Exchange-Traded Self-Indexe… | 0,81% | 28.441.000 | 8. August 2026 | Täglich |
| ZECP · Zacks Trust | 0,80% | 5.541 NS | 31. Mai 2026 | N-PORT |
| IWX · iShares Trust | 0,79% | 54.993 SH | 8. August 2026 | Täglich |
| TAX · EA Series Trust | 0,79% | 408 NS | 29. Mai 2026 | N-PORT |
| BIGY · Tidal Trust II | 0,75% | 409 NS | 30. April 2026 | N-PORT |
| OEI · Listed Funds Trust | 0,75% | 656 NS | 30. April 2026 | N-PORT |
| IVE · iShares Trust | 0,72% | 615.615 SH | 8. August 2026 | Täglich |
| FFLC · FIDELITY COVINGTON TRUST | 0,72% | 16.950 NS | 30. April 2026 | N-PORT |
| JOYT · J.P. Morgan Exchange-Traded Fund Tr… | 0,71% | 1.284 NS | 30. April 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0,70% | 3.534.266 SH | 8. August 2026 | Täglich |
| IUSV · iShares Trust | 0,68% | 322.866 SH | 8. August 2026 | Täglich |